"Ascorbic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant.
| Descriptor ID |
D001205
|
| MeSH Number(s) |
D02.241.081.844.107 D02.241.511.902.107 D09.811.100
|
| Concept/Terms |
Ascorbic Acid- Ascorbic Acid
- Acid, Ascorbic
- L-Ascorbic Acid
- Acid, L-Ascorbic
- L Ascorbic Acid
- Vitamin C
Magnesium Ascorbate- Magnesium Ascorbate
- Ascorbate, Magnesium
- Magnesium di-L-Ascorbate
- Magnesium di L Ascorbate
- di-L-Ascorbate, Magnesium
- Magnesium Ascorbicum
|
Below are MeSH descriptors whose meaning is more general than "Ascorbic Acid".
Below are MeSH descriptors whose meaning is more specific than "Ascorbic Acid".
This graph shows the total number of publications written about "Ascorbic Acid" by people in this website by year, and whether "Ascorbic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 2 | 2 | 4 |
| 1999 | 0 | 2 | 2 |
| 2001 | 1 | 2 | 3 |
| 2002 | 2 | 1 | 3 |
| 2003 | 1 | 2 | 3 |
| 2004 | 0 | 2 | 2 |
| 2005 | 1 | 1 | 2 |
| 2007 | 1 | 1 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 2 | 1 | 3 |
| 2012 | 2 | 2 | 4 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 2 | 2 |
| 2015 | 2 | 2 | 4 |
| 2016 | 1 | 2 | 3 |
| 2017 | 0 | 2 | 2 |
| 2021 | 1 | 2 | 3 |
| 2022 | 1 | 4 | 5 |
| 2023 | 0 | 1 | 1 |
| 2026 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ascorbic Acid" by people in Profiles.
-
Medical Nutrition Therapy for Pediatric Kidney Stone Prevention, Part Two. J Ren Nutr. 2017 03; 27(2):e11-e14.
-
Medical Nutrition Therapy for Pediatric Kidney Stone Prevention, Part One. J Ren Nutr. 2017 01; 27(1):e5-e8.
-
Enzymatic synthesis of magnetic nanoparticles. Int J Mol Sci. 2015 Apr 03; 16(4):7535-50.
-
Petechial rash in a child with autism and Trisomy 21. Pediatr Ann. 2014 Jun; 43(6):224-6.
-
Commentary on "Plasma carotenoids and vitamin C concentrations and risk of urothelial cell carcinoma in the European Prospective Investigation into Cancer and Nutrition." Ros MM, Bueno de Mesquita HB, Kampman E, Aben KK, B?chner FL, Jansen EH, van Gils CH, Egevad L, Overvad K, Tj?nneland A, Roswall N, Boutron Ruault MC, Kvaskoff M, Perquier F, Kaaks R, Chang Claude J, Weikert S, Boeing H, Trichopoulou A, Lagiou P, Dilis V, Palli D, Pala V, Sacerdote C, Tumino R, Panico S, Peeters PH, Gram IT, Skeie G, Huerta JM, Barricarte A, Quir?s JR, S?nchez MJ, Buckland G, Larra?aga N, Ehrnstr?m R, Wallstr?m P, Ljungberg B, Hallmans G, Key TJ, Allen NE, Khaw KT, Wareham N, Brennan P, Riboli E, Kiemeney LA, National Institute for Public Health and the Environment, Bilthoven, Netherlands: Am J Clin Nutr 2012;96(4):902-10 [Epub 2012 Sep 5]. Urol Oncol. 2013 Jul; 31(5):714-5.
-
Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells. Nat Genet. 2012 Mar 04; 44(4):398-405, S1-2.
-
A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid. Cancer. 2012 May 01; 118(9):2507-15.
-
A randomized placebo-controlled crossover trial of aloe vera on bioavailability of vitamins C and B(12), blood glucose, and lipid profile in healthy human subjects. J Diet Suppl. 2010 Jun; 7(2):145-53.
-
Antioxidant genes, diabetes and dietary antioxidants in association with risk of pancreatic cancer. Carcinogenesis. 2010 Apr; 31(4):607-13.
-
Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial. Biol Blood Marrow Transplant. 2008 Dec; 14(12):1401-7.